NASDAQ
Revance Therapeutics, Inc. (RVNC) has a fcf yield of -30.05% as of Friday, May 29, 2026. This represents a 86.34% decrease compared to its 12-month average of -16.13%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.